BB Biotech AG | |
Stock Exchange | Electronic Share Market |
EPS |
- |
Market Cap |
EUR3.37 B |
Shares Outstanding |
59.25 M |
Public Float |
- |
BB Biotech AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
- |
Market Cap |
EUR3.34 B |
Shares Outstanding |
59.25 M |
Public Float |
- |
BB Biotech AG | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF2.51 |
Market Cap |
CHF3.78 B |
Shares Outstanding |
55.4 M |
Public Float |
53.94 M |
Address |
Schwertstrasse 6 Schaffhausen Zurich 8200 Switzerland |
Employees | - |
Website | http://www.bbbiotech.com |
Updated | 09/14/2018 |
BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on companies whose products address areas of significant unmet medical needs and generates above-average sales and profit growth. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland. |